Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...

Charles River is shuttering its pathology facility in Durham, North Carolina, after determining the site “is not a strategic ...

In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Update: On January 31, under the new Trump administration, the U.S. Environmental Protection Agency (EPA) reopened the ...

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, indicating future capital deployment.

The company told state officials that it plans to initially lay off at least 31 employees as it works to close its Pathology Associates International office on Stirrup Creek Drive.

Members of Congress and animal rights advocates believe the Department of Government Efficiency could end animal testing ...

Charles River Laboratories International Inc. (CRL) stock has reached a new 52-week low, touching down at $160.73. This ...

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Colonial Heights’ Appomattox River Greenway Trail is expanding this spring with a half-mile path addition, new bridges and ...